Follicular Lymphoma | Visiting Professors: Selection and Sequencing of Systemic Therapy in the Management of Follicular Lymphoma - a podcast by Dr Neil Love

from 2019-09-13T16:00

:: ::

A presentation on follicular lymphoma featuring perspectives from Dr John P Leonard.

Introduction
- Program Overview: Dr Leonard (00:00)
Optimizing the Care of Patients with Newly Diagnosed Follicular Lymphoma (FL)
- Initiation of active therapy versus watchful waiting; indications for rituximab monotherapy (00:34)
- Choice of systemic therapy for patients requiring treatment; impact of age, tumor bulk and symptomatology (3:55)
- Clinical research data evaluating maintenance therapy; factors influencing its use (15:41)
- Data for and clinical role of subcutaneous rituximab (20:29)
Management of Relapsed/Refractory (R/R) FL
- Factors affecting the sequencing of systemic therapy for R/R disease (eg, previous treatment received, remission duration, symptomatology) (22:37)
- Integration of obinutuzumab in the R/R setting (25:50)
- Role of lenalidomide/rituximab in the management of R/R FL (28:54)
- Available clinical research data with the FDA-approved PI3K inhibitors (34:41)

Further podcasts by Dr Neil Love